Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use?

Histopathological tumor regression grade (TRG) has been shown to be a prognostic factor in patients with esophageal cancer after neoadjuvant radiochemotherapy (RCT). The system introduced by Mandard to group TRG (Cancer 1994;73:2680–2686) has been used to analyse and discuss its prognostic significa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diseases of the esophagus 2006-10, Vol.19 (5), p.329-334
Hauptverfasser:	Hermann, R. M., Horstmann, O., Haller, F., Perske, C., Christiansen, H., Hille, A., Schmidberger, H., Füzesi, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	esophageal carcinoma Esophageal Neoplasms - mortality Esophageal Neoplasms - pathology Esophageal Neoplasms - therapy Female Follow-Up Studies histopathological regression grading Humans Male Middle Aged neoadjuvant radiochemotherapy Neoadjuvant Therapy Neoplasm Staging Prognosis prognostic factors Retrospective Studies Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!